Market Cap 54.95B
Revenue (ttm) 3.90B
Net Income (ttm) 887.87M
EPS (ttm) N/A
PE Ratio 54.11
Forward PE 52.79
Profit Margin 22.78%
Debt to Equity Ratio 0.34
Volume 206,700
Avg Vol 580,128
Day's Range N/A - N/A
Shares Out 79.85M
Stochastic %K 35%
Beta 1.67
Analysts Strong Sell
Price Target $790.67

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test ki...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 207 556 0300
Fax: 207 556 4346
Address:
One IDEXX Drive, Westbrook, United States
1iquid
1iquid Dec. 25 at 4:44 PM
💎 Liquid® Live Actionable Trade Asset: $IDXX Contracts: $IDXX July 17, 2026 $700 Calls Scale in: $72.90- $89.10 Scale out: $283.50-$486.00 Profit Potential : 305% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:38 PM
Actionable Trade Alert for $IDXX: Market Context: $IDXX is currently trading at $688.18, with an RSI of 30.68 indicating it is oversold. The stock is positioned below its 30-day MA of 709.4 and 50-day MA of 691.29, suggesting bearish sentiment. However, the proximity to the 60D low of 600.57 may present a buying opportunity as it approaches a support level. Directional Bias: The oversold RSI and the recent low suggest potential for a rebound. The ATR of 16.29 indicates volatility, providing room for price movement. Trade Plan: - Suggested Entry: $688.18 - Stop Loss: $670.00 (risking $18.18) - Take Profit Targets: 1. $710.00 (TP1: 3.17% ROI) 2. $740.00 (TP2: 7.53% ROI) 3. $805.00 (TP3: 17% ROI) This plan allows for a strategic entry with a favorable risk-reward ratio, targeting a substantial return on the third take profit. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TribbleTrader
TribbleTrader Dec. 24 at 6:38 PM
$IDXX Future valuation dynamics revolve around execution consistency across macro cycles and demand regimes, with outcomes shaped by timing and discipline. Execution clarity would stabilize long‑term sentiment.
0 · Reply
1iquid
1iquid Dec. 21 at 5:33 PM
💎 Liquid® Live Actionable Trade Asset: $IDXX Contracts: $IDXX July 17, 2026 $720 Calls Scale in: $67.86- $82.94 Scale out: $263.90-$452.40 Profit Potential : 155% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 8:19 PM
Hedge Alert Live - Protect Your Portfolio Contract: $IDXX $690.00 Put · JAN 16, 2026 Exp Entry Price: $15.14 - $15.90 Exit Price Target: $24.53 Profit Margin: +62% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:32 PM
Actionable Trade Alert for $IDXX: Market Context: $IDXX closed at $697.1, with a significantly low RSI of 17.69, indicating oversold conditions. The stock is currently positioned between its 60D high of $769.98 and low of $600.57, suggesting potential for a rebound. Directional Bias: Given the low RSI and proximity to the 60D low, there is a bullish bias. The MA30 at $712.31 is above the current price, while the MA50 at $684.65 is below, indicating potential resistance and support levels. Trade Plan: - Suggested Entry: $700 - Stop Loss: $680 (below MA50) - Take Profit Targets: 1. Target 1: $725 (3.57% ROI) 2. Target 2: $750 (7.61% ROI) 3. Target 3: $820 (17.61% ROI) With the potential for a significant upside, this trade aligns with the current market dynamics. Monitor price action closely for entry confirmation. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 18 at 9:48 AM
$IDXX Current Stock Price: $695.54 Contracts to trade: $700 IDXX Dec 19 2025 Call Entry: $3.34 Exit: $5.39 ROI: 61% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:20 AM
Actionable Trade Alert for $IDXX: Market Context: $IDXX closed at $691.56, showing a significant oversold condition with an RSI of 23.44. The stock is currently below its 30-day moving average (MA30) of 714.0 and above its 50-day moving average (MA50) of 681.87, indicating potential upward momentum as it approaches the 50-day MA. Directional Bias: The RSI suggests a strong oversold condition, which often leads to a price rebound. The recent high of 769.98 and low of 600.57 creates a range that supports a bullish outlook as the price is closer to the low. Trade Plan: - Suggested Entry: $691.56 - Stop Loss: $681.00 (below MA50) - Take Profit Targets: 1. $715.00 (Target 1: 3.4% ROI) 2. $740.00 (Target 2: 7.0% ROI) 3. $810.00 (Target 3: 17.1% ROI) This plan capitalizes on the potential for recovery while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 16 at 8:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $IDXX $690.00 Put · JAN 16, 2026 Exp Entry Price: $16.74 - $18.20 Exit Price Target: $38.00 Profit Margin: +127% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 12:58 PM
MedTech stocks to watch in 2026: $ISRG, $PODD, $BSX, $IDXX 🚀 🦾 ISRG: Da Vinci systems drive expected 14.3% revenue growth in 2026, Zacks Rank #1 📈 PODD: Omnipod 5 expansion fuels 19.8% revenue boost, Zacks Rank #2 💉 BSX: WATCHMAN & FARAPULSE tech gain traction, Zacks Rank #2 🐾 IDXX: Companion Animal diagnostics thrive, Zacks Rank #2 Discover why these could outperform 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-body-24744&ADID=SYND_STOCKTWITS_TWEET_2_2804170_BODY_24744
0 · Reply
Latest News on IDXX
IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

Nov 24, 2025, 2:15 PM EST - 4 weeks ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

RMD


Baron Asset Fund Q3 2025 Performance Review

Nov 13, 2025, 2:30 AM EST - 6 weeks ago

Baron Asset Fund Q3 2025 Performance Review

APH CHH FDS IT MORN ONON STUB


Final Trades: Meta, S&P Global and Idexx Lab

Nov 3, 2025, 1:29 PM EST - 7 weeks ago

Final Trades: Meta, S&P Global and Idexx Lab

META SPGI


Idexx Stock Pops on Earnings. Pet Health Is Booming.

Nov 3, 2025, 11:08 AM EST - 7 weeks ago

Idexx Stock Pops on Earnings. Pet Health Is Booming.


IDEXX Laboratories Announces Third Quarter Results

Nov 3, 2025, 6:30 AM EST - 7 weeks ago

IDEXX Laboratories Announces Third Quarter Results


IDEXX Laboratories Elects Karen Peacock to Board of Directors

Oct 7, 2025, 7:00 AM EDT - 2 months ago

IDEXX Laboratories Elects Karen Peacock to Board of Directors


IDEXX Laboratories Announces Second Quarter Results

Aug 4, 2025, 6:30 AM EDT - 5 months ago

IDEXX Laboratories Announces Second Quarter Results


IDEXX Laboratories: A Business With Strong Fundamentals

Jul 17, 2025, 7:06 AM EDT - 5 months ago

IDEXX Laboratories: A Business With Strong Fundamentals


IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

May 14, 2025, 2:35 PM EDT - 8 months ago

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits


IDEXX Laboratories Announces First Quarter Results

May 1, 2025, 6:30 AM EDT - 8 months ago

IDEXX Laboratories Announces First Quarter Results


IDEXX Laboratories: A Top Dog In The Pet Care Market

Mar 12, 2025, 6:24 AM EDT - 10 months ago

IDEXX Laboratories: A Top Dog In The Pet Care Market


IDEXX Laboratories And Its Real Value

Feb 10, 2025, 11:27 AM EST - 11 months ago

IDEXX Laboratories And Its Real Value


IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript

Feb 3, 2025, 11:26 AM EST - 11 months ago

IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript


IDEXX Announces CFO Transition

Nov 21, 2024, 7:30 AM EST - 1 year ago

IDEXX Announces CFO Transition


1iquid
1iquid Dec. 25 at 4:44 PM
💎 Liquid® Live Actionable Trade Asset: $IDXX Contracts: $IDXX July 17, 2026 $700 Calls Scale in: $72.90- $89.10 Scale out: $283.50-$486.00 Profit Potential : 305% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:38 PM
Actionable Trade Alert for $IDXX: Market Context: $IDXX is currently trading at $688.18, with an RSI of 30.68 indicating it is oversold. The stock is positioned below its 30-day MA of 709.4 and 50-day MA of 691.29, suggesting bearish sentiment. However, the proximity to the 60D low of 600.57 may present a buying opportunity as it approaches a support level. Directional Bias: The oversold RSI and the recent low suggest potential for a rebound. The ATR of 16.29 indicates volatility, providing room for price movement. Trade Plan: - Suggested Entry: $688.18 - Stop Loss: $670.00 (risking $18.18) - Take Profit Targets: 1. $710.00 (TP1: 3.17% ROI) 2. $740.00 (TP2: 7.53% ROI) 3. $805.00 (TP3: 17% ROI) This plan allows for a strategic entry with a favorable risk-reward ratio, targeting a substantial return on the third take profit. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TribbleTrader
TribbleTrader Dec. 24 at 6:38 PM
$IDXX Future valuation dynamics revolve around execution consistency across macro cycles and demand regimes, with outcomes shaped by timing and discipline. Execution clarity would stabilize long‑term sentiment.
0 · Reply
1iquid
1iquid Dec. 21 at 5:33 PM
💎 Liquid® Live Actionable Trade Asset: $IDXX Contracts: $IDXX July 17, 2026 $720 Calls Scale in: $67.86- $82.94 Scale out: $263.90-$452.40 Profit Potential : 155% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 8:19 PM
Hedge Alert Live - Protect Your Portfolio Contract: $IDXX $690.00 Put · JAN 16, 2026 Exp Entry Price: $15.14 - $15.90 Exit Price Target: $24.53 Profit Margin: +62% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:32 PM
Actionable Trade Alert for $IDXX: Market Context: $IDXX closed at $697.1, with a significantly low RSI of 17.69, indicating oversold conditions. The stock is currently positioned between its 60D high of $769.98 and low of $600.57, suggesting potential for a rebound. Directional Bias: Given the low RSI and proximity to the 60D low, there is a bullish bias. The MA30 at $712.31 is above the current price, while the MA50 at $684.65 is below, indicating potential resistance and support levels. Trade Plan: - Suggested Entry: $700 - Stop Loss: $680 (below MA50) - Take Profit Targets: 1. Target 1: $725 (3.57% ROI) 2. Target 2: $750 (7.61% ROI) 3. Target 3: $820 (17.61% ROI) With the potential for a significant upside, this trade aligns with the current market dynamics. Monitor price action closely for entry confirmation. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 18 at 9:48 AM
$IDXX Current Stock Price: $695.54 Contracts to trade: $700 IDXX Dec 19 2025 Call Entry: $3.34 Exit: $5.39 ROI: 61% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:20 AM
Actionable Trade Alert for $IDXX: Market Context: $IDXX closed at $691.56, showing a significant oversold condition with an RSI of 23.44. The stock is currently below its 30-day moving average (MA30) of 714.0 and above its 50-day moving average (MA50) of 681.87, indicating potential upward momentum as it approaches the 50-day MA. Directional Bias: The RSI suggests a strong oversold condition, which often leads to a price rebound. The recent high of 769.98 and low of 600.57 creates a range that supports a bullish outlook as the price is closer to the low. Trade Plan: - Suggested Entry: $691.56 - Stop Loss: $681.00 (below MA50) - Take Profit Targets: 1. $715.00 (Target 1: 3.4% ROI) 2. $740.00 (Target 2: 7.0% ROI) 3. $810.00 (Target 3: 17.1% ROI) This plan capitalizes on the potential for recovery while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 16 at 8:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $IDXX $690.00 Put · JAN 16, 2026 Exp Entry Price: $16.74 - $18.20 Exit Price Target: $38.00 Profit Margin: +127% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 12:58 PM
MedTech stocks to watch in 2026: $ISRG, $PODD, $BSX, $IDXX 🚀 🦾 ISRG: Da Vinci systems drive expected 14.3% revenue growth in 2026, Zacks Rank #1 📈 PODD: Omnipod 5 expansion fuels 19.8% revenue boost, Zacks Rank #2 💉 BSX: WATCHMAN & FARAPULSE tech gain traction, Zacks Rank #2 🐾 IDXX: Companion Animal diagnostics thrive, Zacks Rank #2 Discover why these could outperform 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-body-24744&ADID=SYND_STOCKTWITS_TWEET_2_2804170_BODY_24744
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 11:58 AM
Medtech’s next growth wave is taking shape — and these names are leading it 🚀 $ISRG, $PODD, $BSX and $IDXX are highlighted as leaders in medtech innovation, leveraging AI, robotics, and diagnostics as key growth drivers heading into 2026. See how each company is positioned to benefit from these technologies 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-teaser-24735&ADID=SYND_STOCKTWITS_TWEET_2_2804170_TEASER_24735
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 5:53 AM
Actionable Trade Alert for $IDXX: Market Context: $IDXX is currently trading at $704.2, with an RSI of 41.5 indicating a neutral to slightly bearish momentum. The stock is below its 30-day moving average (MA30) of 712.06, suggesting potential resistance at this level. The 50-day moving average (MA50) at 680.73 provides a support level. Directional Bias: The stock has room to move upward given the proximity to the 60-day high of 769.98, while the low of 600.57 sets a solid support base. The ATR of 17.96 indicates volatility, which can be leveraged for potential gains. Trade Plan: - Suggested Entry: $705 - Stop Loss: $680 (below MA50 for protection) - Take Profit Targets: 1. $725 (2.83% gain) 2. $750 (6.50% gain) 3. $825 (17.16% gain) This plan provides a solid risk-reward ratio, aiming for a minimum of 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Nikolay27
Nikolay27 Dec. 12 at 1:19 AM
0 · Reply
Nikolay27
Nikolay27 Dec. 12 at 12:59 AM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 10:46 PM
Actionable Trade Alert for $IDXX: Market Context: $IDXX is currently trading at $710.02, showing a stable position above its 30-day moving average (MA30) of $709.62 and a significant distance above the 50-day moving average (MA50) of $679.37. The RSI at 56.32 indicates a neutral to slightly bullish momentum, suggesting potential for upward movement. Directional Bias: The price is near the 60-day high of $769.98, indicating bullish sentiment. The ATR of 20.0 suggests moderate volatility, allowing for potential price swings. Trade Plan: - Suggested Entry: $712.00 - Stop Loss: $690.00 (3.1% below entry) - Take Profit Targets: 1. TP1: $740.00 (3.9% ROI) 2. TP2: $760.00 (6.8% ROI) 3. TP3: $830.00 (16.7% ROI) With a well-defined risk-reward ratio, this trade plan offers a potential ROI of over 17% on TP3. Monitor market conditions closely. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 2:50 AM
Actionable Trade Alert for $IDXX: Market Context: $IDXX is currently trading at $699.06, showing a stable position within its 60-day range of $600.57 to $769.98. The RSI at 57.71 indicates a neutral to slightly bullish momentum, while the MA30 (704.62) is above the MA50 (676.32), suggesting a potential upward trend. Directional Bias: Given the current RSI and the positioning of the moving averages, there is a bullish bias. The price is close to the MA30, indicating a possible breakout. Trade Plan: - Suggested Entry: $701.00 (above MA30) - Stop Loss: $679.00 (below MA50) - Take Profit Targets: 1. $720.00 (2.71% ROI) 2. $740.00 (5.57% ROI) 3. $820.00 (17.26% ROI) This plan allows for a strategic entry with a favorable risk-reward ratio. Monitor the price action closely for any adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 9 at 9:51 PM
Hedge Alert Live - Protect Your Portfolio Contract: $IDXX $700.00 Put · DEC 19, 2025 Exp Entry Price: $10.74 - $12.30 Exit Price Target: $24.27 Profit Margin: +126% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 2:53 PM
Barclays updates rating for IDEXX Laboratories ( $IDXX ) to Overweight, target set at 850.
0 · Reply
MysticGlide
MysticGlide Dec. 9 at 11:43 AM
$IDXX 722$ into new years
0 · Reply
MysticGlide
MysticGlide Dec. 9 at 11:42 AM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 10:37 PM
Actionable Trade Alert for $IDXX: Market Context: $IDXX is currently trading at $707.16, showing a bullish sentiment as indicated by the RSI of 60.59, which suggests upward momentum but not yet overbought. The price is above both the 30-day MA (702.92) and the 50-day MA (674.96), reinforcing a positive trend. Directional Bias: The recent high of $769.98 and low of $600.57 over the last 60 days indicates a range-bound market with potential for upward movement. The ATR of 21.15 suggests volatility, providing opportunities for profit. Trade Plan: - Suggested Entry: $710.00 - Stop Loss: $688.00 (3.1% below entry) - Take Profit Targets: 1. $740.00 (4.2% gain) 2. $760.00 (7.0% gain) 3. $830.00 (17% gain) This plan offers a structured approach to capitalize on the upward trend while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
iTrade_Price
iTrade_Price Dec. 6 at 7:25 PM
$IDXX - idxx
0 · Reply